11/19/2024
2:17 PM | Nektar Therapeutics (Subject)
ROBIN HOWARD W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
2:28 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:17 AM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:18 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G | |
11/07/2024
3:31 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
7:52 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:15 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:13 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
2:45 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
5:02 PM | CHESS ROBERT (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
11:15 PM | Nektar Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
4:30 PM | Nektar Therapeutics (Filer)
| Form 424B3 | |
05/28/2024
3:51 PM | Nektar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/20/2024
8:12 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:13 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
8:14 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:36 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:12 PM | Nektar Therapeutics (Filer)
| Form ARS | |
04/17/2024
4:03 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
3:38 PM | Nektar Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/15/2024
3:18 PM | Nektar Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
03/14/2024
3:30 PM | Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
Nektar Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
4:11 PM | Nektar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:20 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
7:40 AM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:16 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:17 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:19 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
2:50 PM | Nektar Therapeutics (Subject)
Zalevsky Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
2:51 PM | Nektar Therapeutics (Subject)
Wilson Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:50 AM | Deep Track Capital, LP (Filed by)
Nektar Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
3:25 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:05 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
5:07 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:18 AM | Nektar Therapeutics (Subject)
WHITFIELD ROY A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
11/27/2023
3:55 PM | Nektar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
7:58 PM | Nektar Therapeutics (Issuer)
ROBIN HOWARD W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 PM | Nektar Therapeutics (Issuer)
Wilson Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:02 PM | Nektar Therapeutics (Issuer)
Zalevsky Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
